首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Chinese Medicine

Chinese Medicine杂志,由BioMed Central出版,于2006年创刊,1 issue/year,出版语言English,ISSN:1749-8546,E-ISSN:1749-8546。

投稿咨询
Chinese Medicine
Chinese Medicine
Chinese Medicine
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
7.4
CiteScore
10.4
期刊收录
SCI、SCIE

Chinese Medicine(中文译名:《中医》),ISSN:1749-8546,EISSN:1749-8546,是BioMed Central出版的国际性学术期刊,创刊于2006年,以1 issue/year形式稳定发行,2026年总发文量约208篇。该刊采用OA开放访问,学科归属为INTEGRATIVE & COMPLEMENTARY MEDICINE - PHARMACOLOGY & PHARMACY。该刊是医学、全科医学与补充医学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达7.4,2025年期刊CiteScore为10.4,2025年期刊自引率约2.7%,在中科院期刊分区体系中位列医学大类1区,在所属学科领域具备高学术影响力与国际认可度。Chinese Medicine长期聚焦医学、全科医学与补充医学及相关产业的技术应用前沿,平均审稿周期31 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、全科医学与补充医学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDNetherlands、USA、Australia、South Korea、Taiwan、Pakistan等为核心发文国家与地区;

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学 PHARMACOLOGY & PHARMACY 药学
1区 1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学 PHARMACOLOGY & PHARMACY 药学
2区 2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学 PHARMACOLOGY & PHARMACY 药学
2区 2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INTEGRATIVE & COMPLEMENTARY MEDICINE SCIE Q1 5 / 48

90.6

学科:PHARMACOLOGY & PHARMACY SCIE Q1 29 / 356

92

学科:INTEGRATIVE & COMPLEMENTARY MEDICINE SCIE Q1 4 / 48

92.71

学科:PHARMACOLOGY & PHARMACY SCIE Q1 27 / 356

92.56

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:INTEGRATIVE & COMPLEMENTARY MEDICINE SCIE Q1 3 / 43

94.2

学科:PHARMACOLOGY & PHARMACY SCIE Q1 34 / 354

90.5

学科:INTEGRATIVE & COMPLEMENTARY MEDICINE SCIE Q1 7 / 43

84.88

学科:PHARMACOLOGY & PHARMACY SCIE Q1 40 / 354

88.84


中国学者近期发文

1
Qinggan Jianpi formula attenuates atherosclerosis by suppressing macrophage lactate transport to activate repair genes via H3K18 lactylatio

Author:Zhuang, Xuefeng; Zhang, Rui; Sun, Jiatong; Song, Wenli; Wang, Jing; Han, Yvna; Wang, Jinji; Chen, Hongzhu; Zhu, Zhijie; Liu, Weijia; Li, Lijing

Journal: CHINESE MEDICINE. 2026; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s13020-026-01394-0

2
FeiyanHeji multifunctionally inhibits influenza virus via PA protein degradation and RIG-I signaling pathway potentiatio

Author:Cao, Tongtong; Sun, Wenqiang; Hu, Yan; Liu, Chang; Hou, Yue; Shu, Jing; Zhang, Ningning; He, Qiang; Yang, Wenxian

Journal: CHINESE MEDICINE. 2026; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s13020-026-01372-6

3
Thlaspi arvense attenuates colitis-associated colorectal tumorigenesis through suppression of neutrophil recruitment via the NOD/NF-κB pathwa

Author:Wang, Ziwei; Wang, Wenkai; Wang, Chaowei; Dong, Bijin; Sun, Yunchuan; He, Xinying; Bi, Ling; Wang, Yan

Journal: CHINESE MEDICINE. 2026; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s13020-026-01381-5

4
Schisandrol B protects against lithocholic acid-induced cholestatic liver injury in mice through mitochondrial biogenesi

Author:Yang, Xiao; Liang, Hangfei; Li, Xuan; Tian, Jianing; Fan, Shicheng; Huang, Min; Wan, Jianbo; Zuo, Zhong; Guo, Haibiao; Bi, Huichang

Journal: CHINESE MEDICINE. 2026; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s13020-026-01342-y

5
The role of Traditional Chinese Medicine in the management of liver disease: targeting gut microbiom

Author:Zhang, Yifan; Li, Hongkun; Yu, Fei; Gao, Mengmeng; Wang, Yang; Xin, Siyu; Yang, Jiating; Wang, Zhiwei; Xiang, Lujie; Ru, Qingjing; Jiang, Na

Journal: CHINESE MEDICINE. 2026; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s13020-026-01395-z

6
Jieduquyuziyin prescription for systemic lupus erythematosus: a system-level therapeutic strategy for immunological recalibratio

Author:Gan, Yihong; Liu, Jingqun; Zhou, Shihui; Lin, Ke; Wang, Xinchang; Fan, Yongsheng; Xu, Li; Bao, Jie

Journal: CHINESE MEDICINE. 2026; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s13020-026-01397-x

7
Ganoderma lucidum mediates microglial polarization and ameliorates experimental autoimmune encephalomyelitis by reducing oxidative stress and inhibiting NF-κB/STAT3 pathwa

Author:Zhang, Lu; Chen, Jie; Yuen, Sauchu; Wu, Meiling; Li, Wenting; Yan, Shenyu; Shen, Jiangang

Journal: CHINESE MEDICINE. 2026; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s13020-026-01327-x

8
Moxibustion delays ovarian aging by regulating mitochondrial biogenesis and improving oocyte qualit

Author:Yin, Yaoli; Xu, Yan; Li, Zemin; Chen, Meilin; Song, Ziwei; Li, Hongxiao; Lu, Ge; Shen, Meihong

Journal: CHINESE MEDICINE. 2026; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s13020-026-01375-3

9
ZhiXiaoSanZheng formula ameliorates podocyte injury in diabetic kidney disease by inhibiting ferroptosis: integrated network pharmacology and experimental validatio

Author:Zhou, Shaofeng; Zheng, Huijuan; Zhang, Xinghua; Xia, Chenhui; Jiang, Weimin; Li, Yaotan; Zhang, Jiale; Ruan, Shiwei; Ye, Binhua; Sun, Weiwei; Wang, Yaoxian

Journal: CHINESE MEDICINE. 2026; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s13020-026-01389-x

10
Si-Ni-San alleviates depression-like behavior via regulating the gut microbiota-tryptophan metabolism-AhR/NF-κB pathway axi

Author:Xiao, Qiang; Wen, Zhaoyi; Zhan, Huang; Zhao, Han; Jiao, Yukun; Huang, Dehua; Li, Hui; Chen, Congcong

Journal: CHINESE MEDICINE. 2026; Vol. 21, Issue 1, pp. -. DOI: 10.1186/s13020-026-01390-4


在线咨询

Chinese Medicine

国际简称:CHIN MED-UK参考译名:中医

年发文量:208 CiteScore:10.4 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:80.77%

杂志社联系方式:CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW

Chinese Medicine